Welcome to our dedicated page for Fuller H B Co SEC filings (Ticker: FUL), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Tracking H.B. Fuller’s adhesive empire means parsing dense pages on resin costs, energy surcharges, and safety regulations across five continents. Each new 10-K or 8-K layers chemical terminology over sprawling segment tables, prompting many investors to ask, “How can I start understanding H.B. Fuller SEC documents with AI?”
Stock Titan solves that problem. Our platform ingests every submission the moment it hits EDGAR, then delivers plain-English insights you can act on. Need the packaging division’s margin trend from the latest H.B. Fuller quarterly earnings report 10-Q filing? It’s summarised in seconds. Waiting for an alert on executive trades? We flag H.B. Fuller insider trading Form 4 transactions the instant they post, linking each trade to H.B. Fuller 8-K material events explained right below. Environmental footnotes, foreign-currency impacts, or pension assumptions—our AI-powered summaries turn technical prose into clarity.
Below, every form is ready for download or instant AI review—from the H.B. Fuller annual report 10-K simplified to the latest proxy statement executive compensation tables. Investors rely on this hub to:
- Monitor H.B. Fuller Form 4 insider transactions real-time before earnings calls
- Compare adhesive segment growth with H.B. Fuller earnings report filing analysis
- Track H.B. Fuller executive stock transactions Form 4 alongside cash-flow swings
The result: H.B. Fuller SEC filings explained simply, updated in real time, and enriched with expert context—so you never miss the data that drives decisions.
H.B. Fuller Company (FUL) Executive VP & CFO John J. Corkrean reported changes in his beneficial ownership on Form 4. The filing shows a disposition of 52,196 shares of Common Stock on 08/15/2025. The report details derivative and equity holdings still held by the reporting person, including phantom units that convert 1-for-1 into common shares (159.84 units shown, representing 26,199.97 when combined with a dividend equivalent feature), multiple vested and unvested employee stock options with exercise prices ranging from $43.48 to $77.72 and individual option share counts listed (for example, 41,208, 48,309, 38,376 among others), and restricted stock units that vest in scheduled installments (examples: 1,292.02, 2,830.02, 4,335.92). The Form 4 is signed by an attorney-in-fact on behalf of the reporting person on 08/18/2025. The filing does not state a sale price for the 52,196-share disposition.
H.B. Fuller insider filing: Ms. Heather Campe, Senior Vice President, International Growth, reported transactions dated 08/15/2025. The filing shows a disposition of 22,316.23 shares of common stock in the non-derivative table. On the same date she acquired 36.77 phantom units that convert 1-for-1 into common stock under the company deferred compensation plan and acquired 36.77 underlying shares at an indicated price of $58.97. The report also lists multiple outstanding employee stock options (with strike prices $51.89, $53.57, $64.28, $68.17, $72.94, $77.72) and restricted stock units vesting over 2026–2028, with specific share amounts disclosed for each grant. The form is signed by an attorney-in-fact on 08/18/2025.
Joao Magalhaes, Sr. VP, Engineering Adhesives at H.B. Fuller (FUL), reported an employee option exercise and an offsetting share sale on 08/08/2025. He exercised 1,099 fully vested options with a $33.38 exercise price and sold 1,099 shares at $56.315. Following these transactions his direct beneficial ownership declined from 4,384 shares to 3,285 shares. Table II lists multiple outstanding option grants and restricted stock units, including an 8,853-share option at a $61.30 strike and RSU grants of 130.22, 301.33 and 1,562.29 shares (some RSUs include dividend-equivalent reinvestment). The Form 4 documents a routine exercise and sale and provides the current option and RSU holdings disclosed by the reporting person.
The Form 144 for H.B. Fuller Company reports a proposed sale of 1,099 common shares through Charles Schwab with an aggregate market value of $61,890, to be sold approximately on 08/08/2025 on the NYSE. The filing states these shares were acquired on 08/08/2025 via an employee stock option exercise, with payment described as a broker payment for cashless exercise.
The notice also discloses a recent sale of 1,046 shares on 08/07/2025 generating gross proceeds of $58,787. The signer represents they do not possess any undisclosed material adverse information. Several filer-identification fields in the provided text are blank.
Form 4 discloses that H.B. Fuller (FUL) Senior Vice President of Engineering Adhesives, Joao Magalhaes, executed and immediately sold option-derived shares on 08-07-2025.
- Option exercise: 1,046 employee stock options exercised at $34.43.
- Open-market sale: 1,046 common shares sold the same day at a weighted-average $56.2022 (price range $56.09-$56.275).
- Direct holdings after sale: 3,285 common shares.
- Equity incentives still held: 29,949 vested/unvested options (exercise prices $33.38-$77.72) and 1,994 restricted stock units, most vesting between 2024-2028.
The transaction represents a 24.1 % reduction in Magalhaes’ directly held common stock (from 4,331 to 3,285 shares), yet he retains substantial equity exposure through options and RSUs. No 10b5-1 plan box was ticked, indicating discretionary timing. The sale is modest compared with FUL’s average daily volume and does not meaningfully alter insider ownership at the company level.
H.B. Fuller (FUL) Form 4: Exec VP Business Transformation Nathan D. Weaver reported a modest insider sale on 08/05/2025. He disposed of 213.1901 common shares held in the company 401(k) plan at $56.84 each, shares that had been accumulated via dividend reinvestment from 04/28/2025-07/24/2025. Post-sale, the plan holds zero shares while Weaver retains 6,970 directly owned shares.
The filing also outlines substantial long-term equity exposure:
- 94,841 employee stock options (strike $26.66-$77.72, expirations 2026-2035); options granted before 2024 are fully vested, later grants vest 33%/33%/34%.
- 5,848 phantom units convertible 1-for-1 into common stock upon separation or an elected date.
- 4,298 restricted stock units vesting between 2026-2028.
No other transactions, purchases, or material corporate events were disclosed in this filing.